CV Sciences, Inc.
CVSI
$0.02
$0.008.33%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.74M | 13.38M | 13.79M | 14.37M | 14.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.74M | 13.38M | 13.79M | 14.37M | 14.98M |
| Cost of Revenue | 6.48M | 6.72M | 7.04M | 7.61M | 8.02M |
| Gross Profit | 6.26M | 6.66M | 6.75M | 6.76M | 6.96M |
| SG&A Expenses | 7.15M | 7.35M | 7.62M | 7.95M | 8.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 0.00 | 0.00 | -522.00K | -522.00K | -522.00K |
| Total Operating Expenses | 13.71M | 14.18M | 14.26M | 15.16M | 15.96M |
| Operating Income | -969.00K | -799.00K | -470.00K | -798.00K | -984.00K |
| Income Before Tax | -2.00M | -1.49M | -949.00K | -1.49M | -1.56M |
| Income Tax Expenses | 7.00K | 2.00K | 9.00K | -7.00K | -7.00K |
| Earnings from Continuing Operations | -2.01 | -1.49 | -0.96 | -1.48 | -1.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.01M | -1.49M | -958.00K | -1.48M | -1.55M |
| EBIT | -969.00K | -799.00K | -470.00K | -798.00K | -984.00K |
| EBITDA | -872.00K | -666.00K | -278.00K | -513.00K | -649.00K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 760.53M | 739.71M | 737.06M | 737.12M | 735.12M |
| Average Diluted Shares Outstanding | 760.53M | 739.71M | 737.06M | 737.12M | 735.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |